Laboratory software: which system owns which question, and in what order to buy it

Laboratories buy overlapping software because vendors in each category extend into the others, and a laboratory that buys three products each claiming to do all five jobs ends up with three partial records of the same work. The way out is to decide which system is authoritative for which question before looking at any product. This page sets out the map.

the FDA rule on electronic records and signatures a regulated lab's system must satisfy
Part 11
good laboratory practice for nonclinical studies, 21 CFR
Part 58
the ISO/IEC standard testing and calibration labs are accredited against
17025

Figures in this panel are the rules a laboratory system of record is bought against, named from the regulations themselves and linked in the sources below. They are identifiers, not prices: BioBricks publishes verified prices for synthesis services only, and says so rather than implying an index it does not hold.

The five questions and who owns them

  1. What arrived and where is it. Sample registration, location and chain of custody. A laboratory information system or a dedicated sample management product owns this, and it is the foundation everything else hangs from, because a result that cannot be tied to a registered sample is not evidence of anything.
  2. What was done and what was found. Tests against versioned methods, results, review and release. This is the laboratory information system's core and is the question a regulated laboratory is examined on most closely.
  3. What was tried and why. The experimental narrative, the reasoning, the failures. An electronic lab notebook owns this, and a laboratory information system does it poorly because its data model is built around repeatable tests rather than around one-off experiments.
  4. Where the raw data lives. Instrument files, images and large datasets with their metadata. Scientific data management systems and instrument data systems own this, and the system of record should hold a pointer and the reported result rather than trying to absorb the raw files.
  5. Who is doing what, when. Scheduling, capacity and equipment booking. This is often a separate product or a module, and it is the one most safely bought independently because it touches the record least.

Buying order matters

Establish sample registration and results first, because everything else references them. A notebook bought before a sample registry produces beautifully written experiments referring to samples nobody can locate.

Add the notebook when the narrative work justifies it, and the data management layer when raw file volume becomes a problem rather than in anticipation. Buying all three at once usually means implementing none of them well.

Integration is where the cost hides

Every boundary between two systems is an integration that must carry sample identity without transcription, and each one has to be built, tested and maintained through both products' upgrade cycles. Fewer systems with clear boundaries beats more systems with clever connections.

Ask each vendor what they integrate with today, in production, at a named customer. Integration roadmaps are not integrations.

Bioprocess software, and where it stops being a laboratory system

A process development group needs something the general laboratory systems do not provide: runs rather than samples, time series from a controller rather than single results, and a comparison of batches as curves. That is why this software exists separately, and why trying to hold a bioreactor campaign in a sample oriented system produces a spreadsheet beside it within a month.

Where it stops is the moment the material leaves development. Manufacturing execution, batch records and release belong to another system, and the useful question when buying is which of the two owns the boundary and how a run in one appears in the other. A vendor who answers that with an export is describing a manual step.

Chromatography data systems, and iso 17025 software claims

A chromatography data system is the instrument's other half: it controls the pump and the detector, holds the raw signal, and is where the integration that produces a number happens. That makes it the record rather than a viewer, which is why reprocessing has to be tracked and why a system that lets a peak be re integrated without a trail is unusable in a regulated laboratory. It is also the hardest software to change later, because the methods and the historical data live in it.

Software sold as meeting an accreditation standard is making a narrower claim than it sounds. A standard is met by a LABORATORY, not by a product: the software can hold the records, enforce the reviews and produce the reports that make an assessment easier, and it cannot hold the competence, the method validation or the uncertainty budget. Read such a claim as a feature list and ask which clauses the vendor says it supports.

retrosynthesis software, and where it fits

retrosynthesis software proposes routes backwards from a target to available starting materials, scoring each step against reaction precedent, and its value is in surfacing routes a chemist would not have considered rather than in replacing the judgement. A proposed route still has to be costed and tested, since precedent is not availability.

Common questions

What is the difference between a LIMS and an ELN?
A LIMS is built around samples and repeatable tests with results and release; an electronic lab notebook is built around experiments and narrative. Testing laboratories usually need the first, discovery laboratories the second, and many eventually run both.
In what order should laboratory software be bought?
Sample registration and results first, because everything else references them. Then the notebook when narrative work justifies it, then a data management layer when raw file volume becomes a real problem.
Should one vendor supply everything?
Not necessarily. A single vendor reduces integration work and increases dependency, and suites are usually strong in one module and ordinary in the rest. Decide the boundaries first and then judge whether one vendor covers them well.
Which laboratory software needs validating?
Any system holding data that supports a regulated submission or product, which normally means the system of record and often the instrument data systems. The obligation follows the data, not the product category.

Get a shortlist for your project

Free. We send a shortlist of vendors whose published prices and service scope fit what you described, built from the verified index on this site. We may email you about this enquiry and similar services from this site; opt out any time, including from the first message.

Browse by service class

Sources

Cite or embed this figure

The median advertised gene synthesis price per base pair in the US research synthesis services market was $0.11 in August 2026, across 4 verified vendor service pages recorded in BioBricks Synthesis Price Index.

Cite as: "BioBricks Synthesis Price Index", updated 2026-08-24, https://biobricks.org/laboratory-software/.

Embed this figure (plain HTML, no scripts)
median advertised gene synthesis price per base pair · the US research synthesis services market · August 2026

$0.11

Middle 50%$0.07 – $0.15
verified vendor service pages4

Source: BioBricks Synthesis Price Index

Get a vendor shortlistCompare synthesis prices